Notably, mutations of NF2 are a major cause of neurofibromatosis type 2 and multiple malignancies, including mesothelioma, melanoma, breast cancer, and colorectal cancer (Ferlay et al., 2013; Petrilli and Fernández-Valle, 2016). This evidence concerns the gene NF2 and breast carcinoma.